COVID-19-associated fungal infections
Abstract Coronavirus disease 2019 (COVID-19)-associated invasive fungal infections are an
important complication in a substantial number of critically ill, hospitalized patients with …
important complication in a substantial number of critically ill, hospitalized patients with …
Epidemiology and pathophysiology of COVID-19-associated mucormycosis: India versus the rest of the world
Abstract The coronavirus disease 2019 (COVID-19) pandemic has led to a concerning
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
resurgence of mucormycosis. More than 47,000 cases of mucormycosis were reported in …
COVID-19 and mucormycosis superinfection: the perfect storm
JA Al-Tawfiq, S Alhumaid, AN Alshukairi, MH Temsah… - Infection, 2021 - Springer
Background The recent emergence of the Coronavirus Disease (COVID-19) disease had
been associated with reports of fungal infections such as aspergillosis and mucormycosis …
been associated with reports of fungal infections such as aspergillosis and mucormycosis …
COVID-19–associated mucormycosis: Evidence-based critical review of an emerging infection burden during the pandemic's second wave in India
JM Aranjani, A Manuel, HI Abdul Razack… - PLoS neglected …, 2021 - journals.plos.org
Coronavirus Disease 2019 (COVID-19), during the second wave in early 2021, has caused
devastating chaos in India. As daily infection rates rise alarmingly, the number of severe …
devastating chaos in India. As daily infection rates rise alarmingly, the number of severe …
Invasive fungal infections complicating COVID-19: a narrative review
G Casalini, A Giacomelli, A Ridolfo, C Gervasoni… - Journal of Fungi, 2021 - mdpi.com
Invasive fungal infections (IFIs) can complicate the clinical course of COVID-19 and are
associated with a significant increase in mortality, especially in critically ill patients admitted …
associated with a significant increase in mortality, especially in critically ill patients admitted …
[HTML][HTML] Multicenter case–control study of COVID-19–associated mucormycosis outbreak, India
In support of improving patient care, this activity has been planned and implemented by
Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited with …
Medscape, LLC and Emerging Infectious Diseases. Medscape, LLC is jointly accredited with …
Retinal vascular occlusions in COVID-19 infection and vaccination: a literature review
S Yeo, H Kim, J Lee, J Yi, YR Chung - Graefe's Archive for Clinical and …, 2023 - Springer
Purpose Abnormal hypercoagulability and increased thromboembolic risk are common in
patients with coronavirus disease (COVID-19). COVID-19 has been suggested to cause …
patients with coronavirus disease (COVID-19). COVID-19 has been suggested to cause …
Coronavirus disease 2019–associated mucormycosis: risk factors and mechanisms of disease
S Narayanan, JV Chua… - Clinical Infectious Diseases, 2022 - academic.oup.com
The severe surge of coronavirus disease 2019 (COVID-19) cases on the Indian
subcontinent in early 2021 was marked by an unusually high number of COVID-19 …
subcontinent in early 2021 was marked by an unusually high number of COVID-19 …
[HTML][HTML] Mucormycosis in COVID-19 pandemic: Risk factors and linkages
Mucormycosis is a serious and potentially fatal fungal infection caused by a type of rare but
opportunistic fungal pathogen called mucormycetes. Recently, mucormycosis, also known …
opportunistic fungal pathogen called mucormycetes. Recently, mucormycosis, also known …
Emerging fungal infections: new species, new names, and antifungal resistance
NP Wiederhold - Clinical chemistry, 2022 - academic.oup.com
Background Infections caused by fungi can be important causes of morbidity and mortality in
certain patient populations, including those who are highly immunocompromised or critically …
certain patient populations, including those who are highly immunocompromised or critically …